Results 11 to 20 of about 16,190 (245)

Bupropion versus other antidepressive agents for depression [PDF]

Cochrane Database Syst Rev, 2020
Furukawa T, Ogawa Y, Takeshima N, Hayasaka Y, Chen P, Cipriani A, Barbui C.   +6 more
europepmc   +3 more sources

Milnacipran versus other antidepressive agents for depression. [PDF]

Cochrane Database Syst Rev, 2009
Nakagawa A, Watanabe N, Omori IM, Barbui C, Cipriani A, McGuire H, Churchill R, Furukawa TA.   +7 more
europepmc   +3 more sources

Escitalopram versus other antidepressive agents for depression. [PDF]

Cochrane Database Syst Rev, 2009
Cipriani A, Santilli C, Furukawa TA, Signoretti A, Nakagawa A, McGuire H, Churchill R, Barbui C.   +7 more
europepmc   +3 more sources

Depression clinical trials worldwide: a systematic analysis of the ICTRP and comparison with ClinicalTrials.gov [PDF]

Translational Psychiatry
Major depressive disorder (MDD), commonly known as depression, affects over 300 million people worldwide as of 2018 and presents a wide range of clinical symptoms.
Eugenia D. Namiot, Diana Smirnovová, Aleksandr V. Sokolov, Vladimir N. Chubarev, Vadim V. Tarasov, Helgi B. Schiöth   +5 more
doaj   +2 more sources

Influence of functional health literacy on adherence to antidepressant treatment [PDF]

Revista Gaúcha de Enfermagem, 2022
Objective To verify the influence of patients’ level of functional health literacy on adherence to antidepressant treatment. Method Cross-sectional study, carried out in pharmacies of the Municipal Health Department of Marília-SP, in 2020/2021.
Alessandro Magon de Sá, Vanessa Casagrande, Eduardo Federighi Baisi Chagas, Osni Lázaro Pinheiro   +3 more
doaj   +1 more source

Natural Psychoplastogens As Antidepressant Agents [PDF]

Molecules, 2020
Increasing prevalence and burden of major depressive disorder presents an unavoidable problem for psychiatry. Existing antidepressants exert their effect only after several weeks of continuous treatment. In addition, their serious side effects and ineffectiveness in one-third of patients call for urgent action.
Jakub Benko, Stanislava Vranková
openaire   +4 more sources

The medicalization of life: An interdisciplinary approach

Heliyon, 2023
In recent years, consumption of antidepressant and psychotropic drugs has skyrocketed and, although contemporary life clearly involves countless conflicts, the same can be said of human beings throughout their respective historical moments.Part of the ...
María de la Luz Casas Martínez
doaj   +1 more source

Phenolic Acids as Antidepressant Agents

Nutrients, 2022
Depression is a psychiatric disorder affecting the lives of patients and their families worldwide. It is an important pathophysiology; however, the molecular pathways involved are not well understood. Pharmacological treatment may promote side effects or be ineffective.
Maria Lúcia da Silva Cordeiro, Verônica Giuliani de Queiroz Aquino Martins, Ariana Pereira da Silva, Hugo Alexandre Oliveira Rocha, Vanessa de Paula Soares Rachetti, Katia Castanho Scortecci   +5 more
openaire   +2 more sources

Translational Informatics for Natural Products as Antidepressant Agents [PDF]

Frontiers in Cell and Developmental Biology, 2022
Depression, a neurological disorder, is a universally common and debilitating illness where social and economic issues could also become one of its etiologic factors. From a global perspective, it is the fourth leading cause of long-term disability in human beings.
Rajeev K. Singla, Rajeev K. Singla, Shikha Joon, Shikha Joon, Li Shen, Bairong Shen   +5 more
openaire   +3 more sources

Los placebos, el dolor neuropàtico y de género

Acta Neurológica Colombiana, 2023
INTRODUCTION: the placebos' analgesic effect seems to depend on different factors such as socio-cultural, psychological and genetic aspects. The effects of gender on placebos' analgesic response have rarely been documented in clinical studies, even ...
Carlos B. Moreno, Angela M. Gutiérrez-Alvarez   +1 more
doaj   +2 more sources